Probity Advisors, Inc. - TAKEDA PHARMACEUTICAL CO LTD ownership

Back to all holdings Add to watchlist

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 305 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
Probity Advisors, Inc. ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$270,539
+17.7%
17,488
+19.5%
0.06%
+24.0%
Q2 2023$229,916
+17.5%
14,635
+16.6%
0.05%
+13.6%
Q4 2022$195,749
+24.7%
12,548
+3.8%
0.04%
+12.8%
Q3 2022$157,000–12,093–0.04%–
 Download
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q3 2023
NameSharesValueWeighting ↓
Bartlett & Co. LLC 20,781$2960.01%
Valued Wealth Advisors LLC 231$3,5740.00%
BALDWIN BROTHERS LLC/MA 2,035$29,0390.00%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders